# ACEi ARB Withdrawal in CKD Patients

> **NCT03957161** · NA · WITHDRAWN · sponsor: **University of California, San Francisco**

## Conditions studied

- Chronic Kidney Disease
- Blood Pressure
- Angiotensin-converting Enzyme Inhibitor
- Angiotensin Receptor Blockers

## Interventions

- **OTHER:** Continuation of ACEi and/or ARBs

## Key facts

- **NCT ID:** NCT03957161
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-11
- **Primary completion:** 2023-11
- **Final completion:** 2023-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Currently we are not pursuing this trial due t o limited bandwidth and have not enrolled any participants.
- **Last updated:** 2023-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03957161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03957161, "ACEi ARB Withdrawal in CKD Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03957161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*